The Computational and Neural Mechanisms Linking Decision-making and Memory in Humans
NCT ID: NCT06072378
Last Updated: 2025-12-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
50 participants
INTERVENTIONAL
2023-10-31
2028-09-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
BASIC_SCIENCE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Value-manipulation
Participants with epilepsy will complete a behavioral task in which they use a laptop computer to do a decision-making and memory task.
Value-manipulation
During the decision-making task, different choices are assigned different values probabilistically.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Value-manipulation
During the decision-making task, different choices are assigned different values probabilistically.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Has elected to receive clinically indicated intracranial EEG (electrocorticography (ECoG), stereoelectroencephalography (SEEG)) and/or temporal responsive neurostimulation (RNS) for medication-refractory epilepsy outside of this research study, as determined by treating clinician(s) and per current clinical practice
* Capacity to provide written informed consent
* Language proficiency in English or Spanish
* Willing and able to comply with all study-related procedures
Exclusion Criteria
* Active suicidal ideation with intent, suicide attempt within the last six months, or other serious suicide risk
* Inability to provide informed consent or reliably participate in study assessments, as per the Montreal Cognitive Assessment (MOCA; score \< 26) or in the opinion of the evaluating neuropsychologist.
* Individuals unwilling or unable to undergo electrode implantation procedures
* Medical contraindications to neurosurgery or for general anesthesia, neurosurgery, or an MRI scan (required for electrode implantation)
* Neurological disorder other than epilepsy or other significant brain pathology, if contraindicated in the opinion of implanting neurosurgeon.
* Women who are pregnant
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute of Mental Health (NIMH)
NIH
Rutgers, The State University of New Jersey
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Salman Ehtesham Qasim, Ph.D.
Assistant Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Salman E Qasim, PhD
Role: PRINCIPAL_INVESTIGATOR
Icahn School of Medicine at Mt. Sinai
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Rutgers Robert Wood Johnson Medical School
New Brunswick, New Jersey, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Pro2024002100
Identifier Type: -
Identifier Source: org_study_id